IKT Stock Analysis: Buy, Sell, or Hold?
IKT - Inhibikase Therapeutics, Inc. Common Stock
$1.58
0.00 (0.32%)
▲
5d:
-6.8%
30d:
-19.23%
90d:
+7.14%
HOLD
LOW Confidence
Last Updated: February 3, 2026
Earnings: Mar 26, 2026
Get Alerted When IKT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IKT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IKT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IKT is currently trading at $1.57, which is considered oversold relative to its 30-day fair value range of $1.60 to $1.92.
Technical Outlook: Technically, IKT is in a uptrend. Immediate support is located at $1.49, while resistance sits at $1.88.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+409.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IKT is in a uptrend. Immediate support is located at $1.49, while resistance sits at $1.88.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+409.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.60 -
$1.92
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 409.6% below Wall St target ($8.00)
- CAUTION: Recommendation downgraded due to -6.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.60 -
$1.92
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.49
Resistance Level
$1.88
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.17
Wall Street Target
$8.00
(+409.6%)
Revenue Growth (YoY)
-100.0%
Last updated: February 03, 2026 1:37 PM ET
Data refreshes hourly during market hours. Next update: 2:37 PM
Data refreshes hourly during market hours. Next update: 2:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IKT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 51 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$277 | 60 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 60 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
